Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
Latest VaccinesWork features
View moreDoes obesity make vaccines less effective?
New research suggests that obesity disrupts the immune machinery vaccines rely on, but immune cells in the lungs can compensate.
Achieving immunisation impact through strengthened data systems
Lessons learned from HISP’s eight-year collaboration with Gavi illustrate how open-source platforms and country-level technical assistance can drive rapid advances in immunisation programme management.
Mass grave reveals who really died in Switzerland’s last plague outbreak
Study of 17th-century plague burials suggests disadvantaged young workers faced the highest risk of death.

VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
Our work

Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.

Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.

Civil society support
We provide grants for civil society organisations (CSOs) working to reach zero-dose children and missed communities with vaccines.
Latest Gavi news releases
View allLower-income countries investing record amount in immunisation programmes
Against a backdrop of aid cuts, lower-income countries contributed a record US$ 302 million towards Gavi-supported vaccines for 2025.
Nearly 20 million lives saved in Africa through measles vaccinations
Nearly 20 million measles-related deaths have been averted in Africa since 2000 thanks to increasing vaccination coverage, according to the first-ever detailed analysis of immunisation targets on the continent.
Preventive cholera vaccination resumes as global supply reaches critical milestone
First preventive campaign in over three years launches in Mozambique, with others planned in Bangladesh and the Democratic Republic of the Congo.
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Explore by region:
Africa | Americas | Eastern Mediterranean
Europe | South-East Asia | Western Pacific
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.

